Filing Details

Accession Number:
0001384101-19-000030
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-05 16:48:24
Reporting Period:
2019-03-04
Accepted Time:
2019-03-05 16:48:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1384101 Veracyte Inc. VCYT Services-Medical Laboratories (8071) 205455398
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1769333 C Giulia Kennedy 6000 Shoreline Court
Suite 300
South San Francisco CA 94080
Chief Scientific & Med Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-03-04 17,625 $5.98 66,249 No 4 M Direct
Common Stock Disposition 2019-03-04 17,625 $20.24 48,624 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2019-03-04 17,625 $0.00 17,625 $5.98
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
52,875 2028-03-01 No 4 M Direct
Footnotes
  1. Represents weighted average sales price. Sale prices for the transactions range from $20.00 to $20.77. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  2. The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.